Malin Life Sciences Holdings Ltd - Nov 30, 2021 Form 4 Insider Report for Poseida Therapeutics, Inc. (PSTX)

Signature
/s/ Pat Jennings, Chief Financial Officer
Stock symbol
PSTX
Transactions as of
Nov 30, 2021
Transactions value $
$351,194
Form type
4
Date filed
12/2/2021, 05:33 PM
Previous filing
Nov 29, 2021
Next filing
Dec 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX COMMON STOCK Purchase $196K +28.6K +0.3% $6.85 9.66M Nov 30, 2021 Direct F1
transaction PSTX COMMON STOCK Purchase $126K +18.4K +0.19% $6.85 9.68M Dec 1, 2021 Direct F1
transaction PSTX COMMON STOCK Purchase $29.6K +4.3K +0.04% $6.88 9.68M Dec 2, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported prices in Column 4 are weighted average prices. Those shares were purchased in multiple transactions at per share prices ranging from $6.70 to $6.95 on 11/30/2021; $6.80 to $6.90 on 12/01/2021; and $6.82 to $6.90 on 12/02/2021. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.